Literature DB >> 24055135

A multi faceted quality improvement programme results in improved outcomes for the selective non-operative management of penetrating abdominal trauma in a developing world trauma centre.

G L Laing1, D L Skinner, J L Bruce, W Bekker, G V Oosthuizen, D L Clarke.   

Abstract

INTRODUCTION: The selective non-operative management (SNOM) of penetrating abdominal trauma (PAT) is well established in our environment. As a quality-improvement initiative, we aimed to re-evaluate patient outcomes with PAT. This follows the application of new imaging and diagnostic modalities using protocolised management algorithms.
METHODOLOGY: A prospectively maintained digital registry was retrospectively interrogated and all patients with PAT treated by our service from January 2012 to March 2013 were included in this study.
RESULTS: A total of 325 patients sustained PAT during the fourteen-month study period. This included 238 SWs, 80 GSWs and 7 impalement injuries. 11 patients had eviscerated bowel, and 12 had eviscerated omentum. A total of 123 patients (38%) were selected for a trial of SNOM. This included 103 SWs, 15 GSWs and 5 impalement injuries. Emergency laparotomy was performed on 182 patients (115 SWs, 65 GSWs and 2 impalement injuries) and 21 patients with left sided thoraco-abdominal SWs underwent definitive diagnostic laparoscopy (DL). SNOM was successful in 122 cases (99%) and unsuccessful in one case (1%). In the laparotomy group 161 (88%) patients underwent a therapeutic procedure, in 12 cases (7%) the laparotomy was non-therapeutic and in 9 cases (5%) the laparotomy was negative. In the laparoscopy group (24), two patients required conversion for colonic injuries and one for equipment failure. Seven (33.3%) laparoscopies were therapeutic with the identification and intra-corporeal repair of seven left hemi-diaphragm injuries.
CONCLUSION: We have improved our results with the SNOM of PAT and have also managed to safely and successfully extend the role of SNOM to abdominal GSWs. We have selectively adopted newer modalities such as laparoscopy to assess stable patients with left thoraco-abdominal SWs and abdominal CT scan for the SNOM of abdominal GSWs.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Penetrating abdominal trauma; Selective non-operative management

Mesh:

Year:  2013        PMID: 24055135     DOI: 10.1016/j.injury.2013.08.021

Source DB:  PubMed          Journal:  Injury        ISSN: 0020-1383            Impact factor:   2.586


  5 in total

1.  Predicting the Outcome of Non-operative Management of Splenic Trauma in South Africa.

Authors:  Matthew C Hernandez; Michael D Traynor; Ariel W Knight; Victor Y Kong; Grant L Laing; John L Bruce; Wanda Bekker; Martin D Zielinski; Damian L Clarke
Journal:  World J Surg       Date:  2020-05       Impact factor: 3.352

2.  Delayed laparotomy after selective non-operative management of penetrating abdominal injuries.

Authors:  Miroslav P Peev; Yuchiao Chang; David R King; Daniel D Yeh; Haytham Kaafarani; Peter J Fagenholz; Marc A De Moya; George C Velmahos
Journal:  World J Surg       Date:  2015-02       Impact factor: 3.352

3.  The Quality and Utility of Surgical and Anesthetic Data at a Ugandan Regional Referral Hospital.

Authors:  G Tumusiime; A Was; M A Preston; J N Riesel; S S Ttendo; P G Firth
Journal:  World J Surg       Date:  2017-02       Impact factor: 3.352

4.  Selective non-operative management for penetrating abdominal injury in a Dutch trauma centre.

Authors:  Ojf Van Waes; Emm Van Lieshout; Dj Van Silfhout; J A Halm; Mme Wijffels; Mg Van Vledder; Hp De Graaff; Mhj Verhofstad
Journal:  Ann R Coll Surg Engl       Date:  2020-04-01       Impact factor: 1.891

5.  Outcomes of selective nonoperative management of civilian abdominal gunshot wounds: a systematic review and meta-analysis.

Authors:  Aziza N Al Rawahi; Derek J Roberts; Fatma A Al Hinai; Jamie M Boyd; Christopher J Doig; Chad G Ball; George C Velmahos; Andrew W Kirkpatrick; Pradeep H Navsaria
Journal:  World J Emerg Surg       Date:  2018-11-27       Impact factor: 5.469

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.